Summit Trail Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Summit Trail Advisors's MDT Position: Q1 2026 in Review
Summit Trail Advisors reduced its Medtronic (MDT) stake by 0.55% in Q1 2026, selling an estimated $21.8K and leaving 41,515 shares worth $3.6M. The position accounts for 0.05% of the portfolio, ranked #240.
Summit Trail Advisors first reported a position in MDT in Q4 2017 and has held it in 22 quarters since. The position peaked at $4.49M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Summit Trail Advisors held 41,515 shares of Medtronic worth $3.6M as of Q1 2026.
- Summit Trail Advisors sold 228 Medtronic shares in Q1 2026, an estimated $21.8K.
- Medtronic made up 0.05% of Summit Trail Advisors's portfolio in Q1 2026, its #240 holding.
- Summit Trail Advisors first reported a position in Medtronic in Q4 2017 and has held it in 22 quarters since.
- Summit Trail Advisors's Medtronic position peaked at $4.49M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.